Atea Pharmaceuticals Inc (AVIR)
R&D Expenses
$28.15M
Quarterly · Period ending: · USD
AVIR R&D Expenses
Latest reported$28.15Mperiod ending
Latest reported$28.15Mperiod ending
AVIR Quarterly R&D Expenses ($1.44M → $28.15M)
Quarterly R&D Expenses
High-resolution chart · PNG
AVIR r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 28,150,000 | |
| 41,134,000 | |
| 47,818,000 | |
| 38,347,000 | |
| 32,275,000 | |
| 29,584,000 | |
| 25,671,000 | |
| 26,159,000 | |
| 34,696,000 | |
| 57,575,000 | |
| 35,045,000 | |
| 31,929,000 | |
| 29,940,000 | |
| 29,954,000 | |
| 28,640,000 | |
| 4,905,000 | |
| 19,858,000 | |
| 30,478,000 | |
| 57,811,000 | |
| 43,019,000 | |
| 39,803,000 | |
| 26,571,000 | |
| 13,846,000 | |
| 13,601,000 | |
| 7,755,000 | |
| 2,821,000 | |
| 3,489,000 | |
| 2,411,000 | |
| 2,826,000 | |
| 1,444,000 |